BRAINSTORM CELL THERAPEUTICS INC. (BCLI) › Net IncomeBRAINSTORM CELL THERAPEUTICS INC. (BCLI) — Net IncomeAnnual figures by fiscal year, from SEC filings.2002: -$26.0K2003: -$47.0K2004: -$73.0K2005: -$18.84M2006: -$3.32M2007: -$6.24M2008: -$3.47M2009: -$1.78M2010: -$2.42M2011: -$3.92M2012: -$3.43M2013: -$4.90M2014: -$9.25M2015: -$8.49M2016: -$4.98M2017: -$4.95M2018: -$13.95M2019: -$23.25M2020: -$31.81M2021: -$24.46M2022: -$24.28M2023: -$17.19M2024: -$11.62M2025: -$10.31M-$10.31M2002Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$10.31M+11.3%2024-$11.62M+32.4%2023-$17.19M+29.2%2022-$24.28M+0.7%2021-$24.46M+23.1%2020-$31.81M-36.8%2019-$23.25M-66.7%2018-$13.95M-181.7%2017-$4.95M+0.6%2016-$4.98M+41.3%2015-$8.49M+8.2%2014-$9.25M-88.7%2013-$4.90M-42.8%2012-$3.43M+12.5%2011-$3.92M-62.0%2010-$2.42M-35.8%2009-$1.78M+48.7%2008-$3.47M+44.4%2007-$6.24M-88.2%2006-$3.32M+82.4%2005-$18.84M-25708.2%2004-$73.0K-55.3%2003-$47.0K-80.8%2002-$26.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share